<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Arizona Enacts Law: Pharmaceutical Companies to Legally Communicate Off-Label Treatment to Medical Professionals	</title>
	<atom:link href="https://www.policymed.com/2017/03/arizona-now-allows-pharmaceutical-companies-to-legally-communicate-off-label-treatment-to-medical-pr.html/feed" rel="self" type="application/rss+xml" />
	<link>https://www.policymed.com/2017/03/arizona-now-allows-pharmaceutical-companies-to-legally-communicate-off-label-treatment-to-medical-pr.html</link>
	<description>Legal, Regulatory, and Compliance Issues</description>
	<lastBuildDate>Sat, 05 May 2018 05:25:06 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
</channel>
</rss>